Malignant Mesothelioma brings together the most current diagnostic criteria and treatment plans from the world's leading experts on this rare but devastating cancer. The first edition was a critical and commercial success and this revision builds on that reputation. The editors have brought together the world's leading experts to fully explore the latest scientific breakthroughs in carcinogenesis, immunotherapy, potential vaccination strategies, and gene therapy. The clinical aspects of the book are equally strong, with thorough discussion of epidemiology, etiology, different clinical presentations, imaging (including interventional pulmonology), treatment of benign disease, strategies for multimodality treatment of malignant disease.
Editors: Harvey I. Pass, M.D, Chief, Thoracic Surgery, New York University, New York, NY; Nicholas Vogelzang, M.D, Director, Nevada Cancer Institute, Las Vegas, NV; University of Chicago, Michele Carbone, M.D., Ph.D, Researcher and Director, Thoracic Oncology Program, Cancer Research Center of Hawaii, Honolulu, HI; and Anne S. Tsao, M.D, Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
Publisher: Springer-Verlag New York Inc.
Number of pages: 854
Weight: 3810 g
Dimensions: 254 x 178 x 46 mm
Edition: 2005 ed.
From the reviews:
"Malignant Mesothelioma is an uncommon neoplasm usually associated with exposure to asbestos. ... Harvey Pass and colleagues have edited an up-to-date, comprehensive book that includes a wide range of information, from a historical perspective to descriptions of the latest treatment. ... Laboratory researchers will use it as a resource for information ... of mesothelioma. ... Clinicians will benefit from this complete guide ... . I highly recommend this book to all those who are interested in mesothelioma." (Julie R. Brahmer, The New England Journal of Medicine, March, 2006)
"This is a reference book suitable for departmental and medical libraries and for the shelves of those who have a particular clinical or research interest in mesothelioma ... . Pass, Vogelzang and Carbone envisioned a comprehensive text and have achieved it. ... To be useful such a book must be well indexed; and this is. The individual chapters are well referenced ... . The text is well edited ... . This is a quality production. ... Overall it is highly recommended." (Michael Byrne, CancerForum, Vol. 30 (3), November, 2006)
You may also be interested in...
Please sign in to write a review